Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Est. Listeners
Insufficient chart data. Estimates will improve as the show charts.
- Per-Episode Audience
Est. listeners per new episode within ~30 days
N/A🎙 Weekly cadence·190 episodes·Last published 1w ago - Monthly Reach
Unique listeners across all episodes (30 days)
N/A - Active Followers
Loyal subscribers who consistently listen
N/A
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 10 epsHosts
Recent guests
Recent episodes
Introducing: Early Signals
Jun 19, 2026
0m 54s
Site Realities Series | Navigating Complexity: Communication, Escalation Paths and Site Partnership at Scale
May 29, 2026
16m 25s
Site Realities Series | Building Trust at the Site Level: The CRA as Ambassador and Partner
May 22, 2026
25m 29s
Introducing: Conversations on Commercialization
May 11, 2026
1m 07s
Site Realities Series | From Monitor to Strategic Partner: The Evolution of the CRA Role
May 11, 2026
25m 23s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 6/19/26 | Introducing: Early Signals | What are the signals today that will define the future of oncology treatment tomorrow? The Syneos Health Podcast: Early Signals brings together leaders across biopharma, healthcare, academia and technology to explore the innovations reshaping drug development in oncology. Hosted by experts across Syneos Health, including Wael Harb, MD, Head of Research and Development and Scientific Strategy in oncology, each episode captures candid conversations about emerging science, evolving market dynami... | 0m 54s | ||||||
| 5/29/26 | Site Realities Series | Navigating Complexity: Communication, Escalation Paths and Site Partnership at Scale✨ | communication pathwayssite partnerships+3 | Przemyslaw Wziatek | Syneos Health | PolandUkraine | communicationescalation+3 | — | 16m 25s | |
| 5/22/26 | Site Realities Series | Building Trust at the Site Level: The CRA as Ambassador and Partner✨ | Clinical ResearchSite Relationships+3 | Przemyslaw Wziatek | Syneos Health | PolandUkraine | Clinical Research AssociatesClinical Sites+3 | — | 25m 29s | |
| 5/11/26 | Introducing: Conversations on Commercialization✨ | commercializationbiopharma+3 | — | Syneos Healthbiopharma companies | — | commercializationbiopharma+3 | — | 1m 07s | |
| 5/11/26 | Site Realities Series | From Monitor to Strategic Partner: The Evolution of the CRA Role✨ | clinical research associatesite relationships+4 | Audra Holleman | Syneos Health | — | clinical research associateCRA+5 | — | 25m 23s | |
| 5/1/26 | Site Realities Series | Inside the Site Experience: Challenges, Tradeoffs and Opportunities✨ | clinical researchsite experience+4 | Mimi Fenton | Syneos HealthCedar Health Research+2 | — | clinical trialssite leadership+3 | — | 40m 09s | |
| 2/19/26 | Conversations on Commercialization: Navigating Dermatology’s New Access Landscape with Paul Rittman of Almirall US✨ | dermatologycommercialization+4 | Paul Rittman | Almirall USSyneos Health | — | dermatologycommercialization+5 | — | 22m 35s | |
| 1/30/26 | Functionally Speaking Series: Regulatory Intelligence, Medical Writing and the AI Inflection Point✨ | regulatory intelligencemedical writing+4 | Stuart Goodall | Syneos Health | — | regulatory functionsmedical writing+4 | — | 37m 10s | |
| 1/22/26 | Functionally Speaking Series: Reimagining Site Experience: CRAs, AI and the Future of Functional Models✨ | site experienceCRA role+3 | Bret Couturier | Syneos HealthFSP 360 | — | site experienceCRA+5 | — | 29m 38s | |
| 1/15/26 | Functionally Speaking Series: Modernizing Safety and Pharmacovigilance, The Human in the Loop✨ | SafetyPharmacovigilance+3 | Carol Aliyar | Syneos Health | — | pharmacovigilancesafety+3 | — | 24m 16s | |
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 1/8/26 | Functionally Speaking Series: Clinical Operations for Large Pharma, Navigating Model Evolution With Agility✨ | Clinical OperationsFunctional Service Provider+4 | — | Syneos Healthbiopharma | — | FSP modelbiopharma+4 | — | 29m 45s | |
| 1/8/26 | Functionally Speaking Series: FSP for SMID Sponsors, Navigating Complexity with Flexibility and Trust | What does it take to run a truly effective Functional Service Provider (FSP) model in today’s biopharma landscape? From harmonizing global teams to embedding innovation into daily delivery, FSP engagement is more than a resourcing solution — it’s about strategic collaboration and approaches that accelerate delivery. The Syneos Health Podcast: Functionally Speaking series explores the nuances that make these models work. In this episode of Functionally Speaking, host Lynn Hamilton... | 35m 26s | ||||||
| 1/8/26 |  2025 CNS Summit Series: Scaling Psychedelic Medicines Responsibly, A Conversation with Dr. Dan Karlin, CSO, MindMed | What does it take to redefine psychiatric care with psychedelic therapies? In this episode, Dr. Dan Karlin of MindMed joins host Dr. Talar Hopyan to discuss the clinical, regulatory and cultural shifts underway in mental health. They explore the momentum behind MindMed’s LSD program for anxiety and depression, how the team is preparing for NDA filing and commercialization and why purposeful growth—not hype—is key to long-term success in psychedelics. What you’ll learn: Why M... | 12m 32s | ||||||
| 12/18/25 |  2025 CNS Summit Series: Revolutionizing Clinical Trials with Virtual Patients, A Conversation with Anzar Abbas, CEO, Brooklyn Health | What’s the path to better measurement in psychiatry? In this episode, Dr. Alexandria Wise speaks with Dr. Anzar Abbas—neuroscientist, innovator and CNS Summit 2025 Innovation Showcase winner—about how Brooklyn Health is using AI to standardize rater training and improve data quality in psychiatric trials. They discuss why subjective interviews still dominate, where today’s models fall short and how multimodal digital tools could reshape how we evaluate treatments. Th... | 13m 48s | ||||||
| 12/11/25 |  2025 CNS Summit Series: Rewriting the Rules of Neurodegeneration, A Conversation with Arvinas CSO Angela Cacace, PhD | What if protein degradation could address neurodegenerative diseases, not just cancer? In this episode, Dr. Angela Cacace, CSO at Arvinas, speaks with Dr. Talar Hopyan, Global Head of CST at Syneos Health, about how the company is advancing a degrader targeting LRRK2 in Parkinson’s disease and why early-stage signals in healthy volunteers are raising new possibilities for CNS care. They discuss how Arvinas is engineering blood-brain barrier-penetrant molecules, the translational chall... | 10m 28s | ||||||
| 11/13/25 |  CNS Summit Series: Balanced Disruption in Neurology, A Conversation with Merz Therapeutics CEO Stefan König | Now in its second season, this exclusive CNS Summit podcast series features biopharma leaders sharing bold ideas, breakthrough innovations and what it takes to move smarter and faster for patients. How is a mid-sized, family-owned company scaling with impact in specialty neurology? Stefan König, CEO of Merz Therapeutics, joins guest host Andy Moniz, VP of Therapeutic Strategy and Innovation at Syneos Health at the 2025 CNS Summit. Together, they explore what it takes to lead through vol... | 12m 54s | ||||||
| 11/12/25 | Conversations on Commercialization: Changing the Name Game with Addison Whitney’s Ari™ | A new limited series of the Syneos Health Podcast, Conversations on Commercialization unpacks how biopharma leaders are rewriting the commercial playbook, redefining what it takes to succeed. What if drug naming could be faster, smarter and more aligned to brand strategy? In this episode, Addison Whitney’s Joe Daley, President, and Bill Purdy, SVP and Managing Director of Global Brand Development & Strategy, break down how Ari™, a purpose-built AI platform, is solving long-sta... | 20m 20s | ||||||
| 11/6/25 |  CNS Summit Series: Can Psychedelics Reshape Psychiatry? A Conversation with Kabir Nath, CEO, Compass Pathways | Now in its second season, this exclusive CNS Summit podcast series features biopharma leaders sharing bold ideas, breakthrough innovations and what it takes to move smarter and faster for patients. Compass Pathways CEO Kabir Nath joins host, Dr. Alex Wise, Global Head of Neuroscience at Syneos Health, to discuss the clinical promise of psychedelics and what’s next for psychiatric innovation. What you’ll learn: What’s driving the momentum behind psilocybin therapy Why i... | 12m 53s | ||||||
| 10/23/25 | Conversations on Commercialization: GLP-1 Gold Rush — Who’s Really Winning in the New Obesity Market? | A new limited series of the Syneos Health Podcast, Conversations on Commercialization unpacks how biopharma leaders are rewriting the commercial playbook, redefining what it takes to succeed. In this episode, recorded at Fierce Pharma Week 2025, Tyler Cowan, VP Commercial at Syneos Health, joins Hruta Shah, Senior Engagement Manager for Syneos Health Consulting, to break down the high-stakes race in obesity treatment and the commercial boom around GLP-1 therapies. You’ll he... | 18m 02s | ||||||
| 10/16/25 | Conversations on Commercialization: DTP, AI and the Future of Pharma Access | A new limited series of the Syneos Health Podcast, Conversations on Commercialization unpacks how biopharma leaders are rewriting the commercial playbook, redefining what it takes to succeed. Recorded at Fierce Pharma Week 2025, the series continues with part two of our conversation with Mark Bard, co-founder of the Digital Health Coalition. In this episode, Bard and host Tyler Cowan turn the lens to patients, exploring how direct-to-patient models are disrupting traditional care... | 15m 12s | ||||||
| 10/16/25 | Conversations on Commercialization: The New Rules of HCP Engagement | A new limited series of the Syneos Health Podcast, Conversations on Commercialization unpacks how biopharma leaders are rewriting the commercial playbook, redefining what it takes to succeed. Recorded at Fierce Pharma Week 2025, the series begins with a two-part conversation with Mark Bard, co-founder of the Digital Health Coalition. In this episode, Bard joins host Tyler Cowan, VP, Commercial at Syneos Health to unpack how the pandemic reshaped provider expectations and the... | 20m 21s | ||||||
| 7/29/25 | 2025 Health Trends | Getting Real About Omnichannel: A View from the Leading Edge | Hosted by Drew Beck, Head of Strategy, Growth and Innovation for Syneos Health Learning Solutions, this limited series dives into the breakthrough trends redefining health in 2025 and beyond. From bold moves in R&D and medical affairs to next-gen trial design, product launch strategies and the future of healthcare communications, each episode connects you with the minds driving real change. Big ideas. Real-world impact. Yes, omnichannel is still trending—but it’s also evolving fast.... | 35m 11s | ||||||
| 7/7/25 | Asembia AXS25 Series: Redefining Access for Enhanced Retail Therapies, with Cheryl Allen of Curatio Advisors | In this episode, host Sara Rubin is joined by Cheryl Allen, RPh, founding partner at Curatio Advisors, to explore how manufacturers can evolve their access strategies in response to the growing complexity of specialty-like therapies. With a career spanning specialty pharmacy, digital health innovation and commercialization strategy, Cheryl shares how reframing these products as “enhanced retail” can unlock smarter, patient-centered support models. The conversation highlights how patient voice... | 10m 12s | ||||||
| 6/5/25 | Asembia AXS25 Series: Reimagining Patient Support: Scaling Access, Affordability and AI Integration with Kelly Carter of Amgen | In this special edition of the Syneos Health Podcast recorded from the floor of Asembia’s AXS25 Summit, host Michael Sarshad sits down with Kim Plesnarski, SVP of Market Access and Patient Support Services at Syneos Health and Kelly Carter, AVP of Patient Support at Amgen, to unpack the evolving landscape of patient support. The discussion explores the blurring lines between general and specialty medicine, the growing administrative burden on providers and the need to embed seamless, te... | 19m 12s | ||||||
| 5/29/25 | Asembia AXS25 Series: Redefining Market Access: Patient Support, Technology and Pharma Strategy with Rob Truckenmiller of PharmaCord | In this episode of our Navigating Modern Market Access series, recorded from the floor of Asembia's AXS25 Summit, host Sara Rubin sits down with Rob Truckenmiller, the newly appointed CEO of PharmaCord. Drawing from his deep experience across small, mid-sized and large pharmaceutical companies, Rob explores how market access strategies must evolve to meet today’s healthcare challenges. From the integration of patient services and payer strategies to the role of technology and data in sh... | 9m 43s | ||||||
Showing 25 of 196
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.